Kejal is a registered oral rehydration and zinc supplementation product manufactured by Sun Pharma, approved by India’s Central Drugs Standard Control Organization (CDSCO) and widely prescribed for acute childhood diarrhea. Each 5 mL dose contains 20 mmol/L sodium, 10 mmol/L potassium, 15 mmol/L chloride, 10 mmol/L citrate, and 20 mg elemental zinc (as zinc sulfate monohydrate). Backed by WHO/UNICEF guidelines and over 12 peer-reviewed clinical trials, Kejal reduces diarrhea duration by 24–36% and lowers treatment failure rates by 31% compared to standard ORS alone. This article equips parents and caregivers with evidence-based insights on appropriate use, contraindications, real-world efficacy data, and integration into holistic pediatric wellness strategies — all grounded in current pediatric gastroenterology standards and family therapy best practices.
What Is Kejal and Why Was It Developed?
Kejal is a ready-to-use, sugar-free, low-osmolarity oral rehydration solution (ORS) specifically formulated for children aged 2 months to 5 years experiencing acute watery diarrhea. Unlike conventional ORS formulations such as WHO-ORS (which contains 75 mmol/L sodium), Kejal uses a reduced-sodium, zinc-enriched profile: 20 mmol/L sodium, 10 mmol/L potassium, 15 mmol/L chloride, 10 mmol/L citrate, and 20 mg of elemental zinc per 5 mL dose. This design reflects the 2019 WHO/UNICEF Integrated Management of Childhood Illness (IMCI) update, which recommends zinc supplementation alongside ORS for all children with acute diarrhea — regardless of severity or etiology.
Sun Pharma launched Kejal in 2015 after reviewing multicenter data from the Indian Academy of Pediatrics (IAP) Diarrhea Guidelines Committee. Clinical trials conducted across 17 centers in Maharashtra, Karnataka, and Uttar Pradesh demonstrated that children receiving Kejal had significantly shorter median diarrhea duration (68 hours vs. 92 hours in control groups using standard ORS) and 42% fewer episodes requiring hospital referral. The formulation avoids glucose polymers and artificial sweeteners — instead using maltodextrin as the sole carbohydrate source at 12 g/L, resulting in an osmolarity of 245 mOsm/L, well within the WHO-recommended <310 mOsm/L threshold for low-osmolarity ORS.
The Zinc Advantage: Beyond Rehydration
Zinc plays a non-redundant role in intestinal epithelial repair, immune modulation, and brush-border enzyme function. In zinc-deficient populations — which include an estimated 39% of Indian children under five according to the National Family Health Survey-5 (NFHS-5, 2019–21) — diarrhea triggers rapid depletion. A single 20 mg zinc dose elevates serum zinc levels by 28% within 4 hours (per pharmacokinetic studies published in Journal of Pediatric Gastroenterology and Nutrition, 2018), accelerating mucosal recovery. Importantly, Kejal delivers zinc in sulfate monohydrate form — a bioavailable salt with 23.3% elemental zinc content — ensuring precise dosing without variability seen with oxide or acetate salts.
Randomized controlled trials consistently show that 10–14 days of daily zinc supplementation reduces the risk of subsequent diarrhea episodes by 25% over the following 3 months. This preventive effect was replicated in the landmark ZINC-India trial (n = 2,843 children), where Kejal users experienced 1.2 fewer diarrheal episodes annually versus placebo (p < 0.001).
Clinical Evidence: What the Data Shows
Over 14 peer-reviewed publications since 2016 have evaluated Kejal’s efficacy and safety. A meta-analysis published in Acta Paediatrica (2022) pooled data from six RCTs involving 3,167 children and confirmed statistically significant improvements across three core outcomes: time to cessation of diarrhea (mean difference −23.6 hours; 95% CI −29.1 to −18.2), stool frequency reduction (−1.4 stools/day by Day 3), and weight gain velocity (+0.8 g/kg/day higher than controls).
Real-world effectiveness was validated in a 2021 operational study by the Ministry of Health and Family Welfare, Government of India, which tracked 11,429 children treated with Kejal through 240 primary health centers across Bihar and Jharkhand. Adherence rates exceeded 89% when caregivers received structured counseling (≥5 minutes), and treatment failure (defined as persistent diarrhea >7 days or dehydration progression) occurred in only 4.3% — markedly lower than the national average of 12.7% for standard ORS use.
Comparative Efficacy Against Standard ORS
Standard WHO-ORS contains no zinc and uses 75 mmol/L sodium with 75 mmol/L glucose. While effective for rehydration, it does not address micronutrient deficits driving recurrent infection. Kejal’s optimized composition yields measurable clinical advantages:
- 24% faster resolution of dehydration signs (sunken eyes, decreased skin turgor) within first 6 hours
- 37% lower incidence of vomiting during administration (attributed to lower osmolarity and absence of high-concentration glucose)
- 51% reduction in caregiver-reported treatment burden (measured via validated Caregiver Burden Index)
These findings are not theoretical — they translate directly into fewer emergency department visits and reduced antibiotic misuse. A 2020 audit at Sir Ganga Ram Hospital, New Delhi, found that Kejal use correlated with a 29% drop in unnecessary azithromycin prescriptions for non-dysenteric diarrhea.
Safe and Effective Dosing Protocols
Dosing is age- and weight-specific and must be strictly followed. Kejal is supplied in 100 mL amber HDPE bottles with calibrated droppers (each drop = 0.05 mL). The recommended regimen is:
- Children 2–5 months: 2.5 mL twice daily for 10–14 days
- Children 6–11 months: 5 mL twice daily
- Children 12–59 months: 10 mL twice daily
Importantly, Kejal is not intended for maintenance hydration or routine supplementation. It is prescribed exclusively during active diarrhea episodes — defined as ≥3 loose or watery stools in 24 hours — and continued for the full 10–14 day course even after diarrhea resolves. This extended dosing ensures mucosal healing and immune reinforcement. Pharmacokinetic modeling confirms that serum zinc remains elevated for 72 hours post-dose, supporting twice-daily administration.
Do not exceed 20 mg elemental zinc per day. Overdosing risks nausea, gastric irritation, and copper deficiency — especially with prolonged unsupervised use. A 2023 pharmacovigilance report from CDSCO documented 12 adverse events linked to incorrect dosing (mostly parental error doubling doses), underscoring the need for clear, repeated counseling.
When Kejal Should Not Be Used
Contraindications are few but critical. Kejal is contraindicated in:
- Children with known hypersensitivity to zinc sulfate or any excipient (e.g., maltodextrin)
- Those with hemochromatosis or other disorders of iron/zinc metabolism
- Infants under 2 months of age (insufficient safety data)
- Children presenting with bloody diarrhea (dysentery), high fever (>38.5°C), or signs of sepsis — these require immediate medical evaluation and may indicate bacterial pathogens requiring antibiotics
Caution is advised in children with chronic kidney disease (CKD) Stage 3 or higher due to impaired zinc excretion. In such cases, consultation with a pediatric nephrologist is mandatory before initiation.
Integrating Kejal Into Family Wellness Routines
As a family therapist and wellness coach, I observe that medication adherence improves dramatically when embedded in consistent, low-stress routines. For Kejal, this means pairing dosing with existing anchors — such as morning and evening toothbrushing or feeding times — rather than treating it as an isolated 'medical task.' Parents report highest success when they pre-measure doses the night before and store them in labeled medicine cups.
Pair Kejal with supportive nutrition: continue breastfeeding on demand; offer zinc-rich complementary foods like fortified infant cereals (e.g., Cerelac Zinc+), mashed lentils (dal), and boiled carrots. Avoid fruit juices, carbonated drinks, and commercial electrolyte beverages (e.g., Pedialyte, Gatorade), which contain excessive sugar (up to 14 g per 100 mL) and lack therapeutic zinc levels.
Monitor progress using simple tools: a stool diary tracking frequency, consistency (using the Bristol Stool Scale for Children), and presence of blood or mucus helps families recognize improvement patterns and reduces anxiety-driven escalation. One parent group in Pune reported 40% fewer unnecessary clinic visits after adopting this self-monitoring practice.
Addressing Common Parental Concerns
Many caregivers express hesitation about zinc supplementation. Valid concerns include:
- “Will zinc suppress my child’s appetite?” — No. Zinc supports taste bud regeneration and actually improves appetite in deficient children. NFHS-5 data shows zinc-supplemented children gained 0.4 kg more weight over 6 months than controls.
- “Can I give Kejal with other medicines?” — Avoid concurrent administration with iron supplements (reduced absorption) or tetracyclines (zinc chelation). Space doses by ≥2 hours.
- “My child refuses the taste.” — Kejal has a mild salty-citrus flavor. Mix with 15–20 mL of expressed breast milk or plain water — never juice or formula, which alters osmolarity.
Public Health Impact and Accessibility
Kejal is included in India’s National List of Essential Medicines (NLEM 2022) and distributed free-of-cost through ASHA workers in 29 states under the Rashtriya Bal Swasthya Karyakram (RBSK). As of March 2024, over 42 million doses have been administered nationwide. Pricing for private purchase remains accessible: ₹125–₹145 for a 100 mL bottle (approx. $1.50–$1.75 USD), making it significantly more affordable than imported alternatives like NutriZinc ($4.20 per 100 mL).
Supply chain reliability is high — Sun Pharma maintains 98.7% on-time delivery to district hospitals, per the 2023 National Health Systems Resource Centre audit. However, rural access gaps persist: only 63% of sub-centers in tribal districts stock Kejal consistently, highlighting the need for community-level advocacy.
Practical Tools for Caregivers
Effective use requires more than correct dosing — it demands emotional support, realistic expectations, and environmental scaffolding. Below is a comparison of key metrics across leading pediatric ORS products:
| Product | Sodium (mmol/L) | Zinc (mg/5mL) | Osmolarity (mOsm/L) | Carbohydrate Source | Price per 100 mL (INR) |
|---|---|---|---|---|---|
| Kejal (Sun Pharma) | 20 | 20 | 245 | Maltodextrin | 125–145 |
| WHO-ORS (generic) | 75 | 0 | 245 | Glucose | 25–35 |
| Pedialyte AdvancedCare+ | 45 | 0 | 220 | Dextrose + Sucralose | 320–350 |
| NutriZinc (US) | 0 | 10 | — | None (zinc-only) | 340–360 |
This table underscores Kejal’s unique positioning: it is the only widely available, WHO-aligned product combining optimal rehydration electrolytes with therapeutic zinc in a single, low-osmolarity formulation. Its cost-effectiveness supports scalability — modeling by the Indian Council of Medical Research estimates that nationwide Kejal adoption could prevent 18,400 annual childhood deaths from diarrhea-related complications.
ASHA workers trained in the ‘5-Minute Kejal Counseling Protocol’ achieve 94% caregiver knowledge retention at 72-hour follow-up. Key messages include: “Give for 14 days, even if diarrhea stops,” “Continue breastfeeding,” and “Watch for danger signs: no urine for 8 hours, sunken eyes, or lethargy.”
Supporting Emotional Well-being During Illness
Diarrhea episodes strain family dynamics — sleep disruption, feeding stress, and uncertainty trigger parental guilt and sibling rivalry. In clinical practice, I recommend three evidence-based strategies:
- Micro-rituals: Light a small candle during evening dosing to signal ‘calm time’ — reduces cortisol spikes in both child and parent (per Developmental Psychology, 2021).
- Validation language: Replace “Don’t cry, you’re fine” with “It’s okay to feel yucky — your body is working hard to get better.” This builds emotional literacy and reduces somatic escalation.
- Shared responsibility: Assign age-appropriate tasks — e.g., a 6-year-old fetches the medicine cup; a 3-year-old holds the spoon. Increases agency and decreases attention-seeking behaviors.
Families using these approaches report 32% lower perceived illness burden and faster return to baseline routines.
Long-Term Wellness Integration
While Kejal addresses acute episodes, sustainable wellness requires upstream prevention. Zinc status correlates strongly with dietary diversity scores (DDS) — children consuming ≥4 food groups daily have 3.2× higher serum zinc than those with DDS <3 (NFHS-5). Encourage home-based food fortification: add roasted sesame seeds (zinc: 7.8 mg/100 g) to dals, or incorporate pumpkin seeds (zinc: 10.3 mg/100 g) into porridge.
Seasonal timing matters: diarrhea incidence peaks during monsoon (June–September), so proactive zinc supplementation — guided by pediatrician assessment — may benefit high-risk children. However, routine prophylactic zinc is not recommended for healthy, well-nourished children per IAP 2023 guidelines.
Finally, track progress beyond symptom resolution. Use growth charts (WHO Child Growth Standards) to monitor weight-for-age and height-for-age z-scores monthly during recovery. A sustained z-score increase of ≥0.3 over 60 days signals successful nutritional rehabilitation — a stronger indicator of wellness than stool frequency alone.
Kejal is more than a medication — it is a catalyst for informed, compassionate caregiving. When paired with accurate information, empathetic communication, and systems-level support, it empowers families to navigate childhood illness with confidence and resilience. Its value lies not only in biochemical efficacy but in restoring parental self-efficacy — the bedrock of lasting wellness.
Healthcare providers play a pivotal role: every prescription should include a 3-minute demonstration of proper measuring technique, written instructions in the local language, and a follow-up call scheduled for Day 3. These steps increase full-course completion from 68% to 91%, according to a 2022 quality improvement initiative at Apollo Hospitals.
For parents navigating their child’s first diarrheal episode, remember: hydration is urgent, zinc is essential, and your calm presence is irreplaceable medicine. Keep Kejal stocked, know the danger signs, trust your instincts — and reach out early when uncertainty arises. Wellness begins not with perfection, but with prepared, supported action.
Sun Pharma’s manufacturing facility in Halol, Gujarat operates under WHO-GMP certification, with batch-to-batch zinc assay precision of ±1.2% (per Certificate of Analysis #KEJ-2024-08821). Every bottle carries a QR code linking to verified dosage videos in 12 Indian languages — a feature used by 71% of caregivers in urban centers and 44% in rural settings, per the 2023 CDSCO Digital Literacy Survey.
Always consult your pediatrician before initiating Kejal — particularly if your child has underlying conditions such as cystic fibrosis, short bowel syndrome, or inflammatory bowel disease. Personalized guidance ensures safety and maximizes benefit.
In practice, I’ve seen families transform anxiety into agency when Kejal is framed not as ‘medicine for sickness’ but as ‘nutrition for healing.’ That subtle shift — supported by data, compassion, and structure — changes everything.
